Nordic Pharma Americas, Asia, and Pacific is the newest affiliate of Nordic Group and the first outside of Europe. Nordic AAP is responsible for the commercialization of products on behalf of Nordic Group in the Americas, Asian, and Pacific regions of the world.
Nordic Group is a privately owned pharmaceutical company with a presence in over 17 countries that focuses on the development and commercialization of niche hospital, retail, and orphan products to respond to unmet medical needs. Nordic Group expertise relies on the development and sales of its own products, and on partner products acquired at various stages of development.
Established as Nordic Drugs in 1995 in Sweden, Nordic rapidly expanded activities to other Scandinavian countries before establishing national sales and marketing divisions throughout Europe. Over the years, the collective Nordic Group developed the business to include pharmaceutical manufacturing and development before becoming a truly international operation with the establishment of Nordic AAP in 2020.